Literature DB >> 19011602

Is vasoproliferative tumour (reactive retinal glioangiosis) part of the spectrum of proliferative vitreoretinopathy?

P Hiscott1, H Mudhar.   

Abstract

OBJECTIVES: To investigate the involvement of retinal pigment epithelial (RPE) cells in reactive retinal glioangiosis (RRG; known also as retinal vasoproliferative tumour or massive retinal gliosis).
METHODS: Nine RRG lesions (six in enucleated eyes and three endoresection specimens) were studied employing histological methods. Eight of the nine lesions were also subjected to immunohistochemical evaluation of glial and RPE cell content.
RESULTS: All lesions consisted of masses within the sensory retina that contained glial cells, abnormal blood vessels, and scattered melanin pigment. Epi- and subretinal membranes were also observed in association with the RRG lesions in all six enucleated eyes (retinal surfaces could not be examined in endoresection specimens). Immunohistochemistry revealed RPE cells in seven of eight RRG lesions and in the associated periretinal membranes. These RPE cells were typically fibroblastic or macrophage-like in phenotype and, within RRG lesions, often perivascular in location. Glia represented the majority of cells in the retinal masses.
CONCLUSIONS: The findings indicate that RPE cells may be involved in RRG. The observations engender speculation that RRG represents a part of the spectrum of proliferative vitreoretinopathy, in which case therapies designed to counter proliferative vitreoretinopathy might also have a role in the management of RRG.

Entities:  

Mesh:

Year:  2008        PMID: 19011602     DOI: 10.1038/eye.2008.351

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases.

Authors:  Lynn J Poole Perry; Frederick A Jakobiec; Fouad R Zakka; Elias Reichel; Martina C Herwig; Arie Perry; Daniel J Brat; Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2012-12-06       Impact factor: 5.258

2.  [Histological findings in bilateral asymmetrical vasoproliferative retinal tumor].

Authors:  S Bajorat; S Koinzer; J H Bräsen; H H Hugo; J Roider
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

3.  Pseudoangiomatous retinal gliosis (PARG) treated with iodine plaque in patient with chronic retinal detachment.

Authors:  Marilyn A Marquez; Jorge Fortun; Prashanth Iyer; J William Harbour; Luis J Haddock
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-11

4.  Proliferative Vitreoretinopathy in Treated Retinoblastoma.

Authors:  Cindy S Hwang; Pia R Mendoza; Jill R Wells; Hans E Grossniklaus; G Baker Hubbard
Journal:  Ophthalmol Retina       Date:  2017 Mar-Apr

Review 5.  Imaging of retinal and choroidal vascular tumours.

Authors:  H Heimann; F Jmor; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

6.  Retinitis Pigmentosa Associated with Vasoproliferative Tumors and Coats-like Fundus.

Authors:  Fariba Ghassemi; Marjan Akbari-Kamrani
Journal:  J Ophthalmic Vis Res       Date:  2013-07

7.  Retinal vasoproliferative tumor - A proposal for classification.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

8.  Retinal Vasoproliferative Tumor in Ocular Albinism.

Authors:  Wael A Alsakran; Nada H Almadhi; Abdulaziz A Alshamrani; Yahya A Alzahrani
Journal:  Am J Case Rep       Date:  2020-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.